Josh Marino 🦞

AI & robotics consultant • OpenClaw Hermes fanatic & power user • Building/optimizing autonomous agents daily • #AllIntegration #OpenClaw

[Josh Marino 🦞 @AIRoboticsInt]

Biggest difference between Hermes and @Openclaw is Hermes just works, 0 babysitting and you end up focusing on productivity over babysitting

[Elon Musk @elonmusk]

This provides some sense of scale

[SciTech Girl @scitechgirl]

🚨 AI Just Created a Material Humans Never Imagined!

Scientists have developed a revolutionary new material that is stronger than steel, lighter than foam, and up to 5 times stronger than titanium.

The most surprising part? It was designed by artificial intelligence, not human engineers.
Using AI, researchers created entirely new microscopic structures that were later 3D-printed and tested. The results could lead to lighter airplanes, stronger buildings, and more efficient vehicles.

This breakthrough shows that AI is no longer just helping scientists—it’s starting to invent alongside them.
What could the world look like when AI designs the materials of the future?

Source:
University of Toronto. AI-designed nanomaterials achieve exceptional strength and lightness. University of Toronto Engineering News.

[OpenClaw🦞 @openclaw]

"You can run OpenClaw inside your company now." Annoucing our work with @Microsoft to bring OpenClaw to the Microsoft and Windows ecosystems. Claws now work securly in the enterprise.

[Alsa @AIsaOneHQ]

🚀MiniMax M3 is now available on AIsa

• Frontier coding
• Agentic performance
• 1M context window
• Native multimodality

Now available through AIsa’s OpenAI-compatible API

And the best part: AIsa gives you access at $0.20 input / $0.84 output per 1M tokens, cheaper than other provider's pricing > @MiniMax_AI

Same model. Better route for builders!

[Factory @FactoryAI]

Introducing model routing to Factory.

Factory Router picks the right model for every task, automatically.

Maintain frontier performance while cutting costs by 25%.

[Polymarket @Polymarket]

JUST IN: OpenAI launches "Sites," allowing users to generate and deploy websites within Codex.

[Nous Research @NousResearch]

The next evolution of Hermes Agent is here!

Introducing Hermes Desktop: everything you love about Hermes, now native on your machine.

First demoed in Jensen's GTC keynote, it's now in public preview.

[Mario Nawfal @MarioNawfal]

🇺🇸 6 million American kids are getting a $1,000 stock portfolio next month whether their parents know about it or not.

Trump Accounts launch on July 4th. IRA-style savings accounts for every American under 18, with the government seeding $1,000 for kids born during Trump's second term.

Parents can add up to $5,000 a year tax-free. Michael Dell is throwing in $250 per account for kids who missed the cutoff. Nicki Minaj is contributing up to $300,000 for her fans' kids.

Leave it alone for 18 years and that $1,000 becomes $10,000-$20,000 minimum.

The catch: you have to sign up yourself. Nobody's doing it for you.

TrumpAccounts .gov. Form 4547. Go.

Source: NY Post

[Kalshi @Kalshi]

JUST IN: US Space Force awards $4.20 billion contract to SpaceX

[Nicolas Hulscher, MPH @NicHulscher]

BREAKING: Largest Human Cancer Study of Ivermectin + Mebendazole Is Now PEER-REVIEWED and PUBLISHED in a MAJOR Cancer Journal

84.4% of cancer patients taking ivermectin + mebendazole for 6 months declared either CANCER DISAPPEARANCE, TUMOR REGRESSION, or CANCER STABILIZATION.

Our study, “Real-world Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients: Results from a Prospective Observational Cohort,” is now peer-reviewed and published in Anticancer Research—a major international oncology journal of the International Institute of Anticancer Research (IIAR), established in 1995.

The results represent one of the most compelling clinical signals ever documented for repurposed anti-parasitic therapies in oncology.

A diverse population of cancer patients (n=197) was prescribed compounded ivermectin–mebendazole through a U.S. telemedicine platform, with each capsule containing 25 mg ivermectin and 250 mg mebendazole.

Participants were followed for approximately six months using standardized digital surveys assessing cancer outcomes, medication adherence, and tolerability.

At approximately six months post-treatment initiation, we observed an 84.4% Clinical Benefit Ratio (CBR)—meaning more than four out of five patients reported either:
No evidence of disease (32.8%)
Tumor regression (15.6%)
or Cancer stabilization (36.1%)

Importantly, adherence was remarkably high, with 86.9% completing the initial prescription and 66.4% remaining on therapy at six months.

Side effects were predominantly mild and manageable, reported in 25.4% of patients (primarily gastrointestinal), with 93.6% of those experiencing side effects continuing treatment after minor dosing adjustments.

This groundbreaking peer-reviewed publication was made possible through a unique collaboration between The Wellness Company, the McCullough Foundation, and the Chairman of the President’s Cancer Panel—uniting real-world clinical data, frontline medical experience, and epidemiologic expertise to evaluate inexpensive, repurposed therapies with major translational potential.

With these extraordinarily promising results, double-blind, placebo-controlled clinical trials are now required.

In the meantime, many cancer patients are exercising their right to try.

@twc_health @McCulloughFund @IIAR_Journals @P_McCulloughMD @DrHarveyRisch @DrKellyVictory @jathorpmfm @drdrew @PeterGillooly @FosterCoulson

[Vlad Tenev @vladtenev]

The official @TrumpAccounts app is available for download today, with a full rollout coming in the weeks ahead for everyone eligible who completes IRS Form 4547.

The app is simple, intuitive, and educational, and was designed under the direction of the @USTreasury in close partnership with @ndstudio, @RobinhoodApp and @BNYglobal.

[Polymarket @Polymarket]

NEW: AI startup “Meow” claims its AI agents can form companies, get EINs, open bank accounts, issue cards, and move money from a single prompt.

[Kalshi @Kalshi]

JUST IN: 80% chance Tesla and SpaceX merge within the next year

[First Squawk @FirstSquawk]

ANTHROPIC LAUNCHES CLAUDE OPUS 4.8; NOW ACCESSIBLE EVERYWHERE.

[First Squawk @FirstSquawk]

ANTHROPIC SETS CLAUDE OPUS 4.8 FAST MODE PRICES AT $10 PER MILLION INPUT TOKENS AND $50 PER MILLION OUTPUT TOKENS.

[Watcher.Guru @WatcherGuru]

JUST IN: American Airlines $AAL rises over 7% after announcing it will install Elon Musk's Starlink Wi-Fi to its airplanes.

[Crémieux @cremieuxrecueil]

Eli Lilly has done it.

They've gone and made what seems to be a powerful, permanent gene therapy for LDL cholesterol.

That means they'll be able to effectively prevent most heart disease with a single infusion!

[Mario Nawfal @MarioNawfal]

Cybertruck is starting to make gas pickups look financially exhausting.

More than 10x cheaper per mile.

$73 spent on electricity for 3,376 miles.
Equivalent gas-truck fuel cost?
Around $800.

This wasn’t gentle city driving either.
100% home charging.
80% self-driving.
Rugged terrain through Yellowstone.

The per-mile math is getting brutally one-sided.

@Tesla

[Josh Marino 🦞 @AIRoboticsInt]

RT @MarioNawfal: 🚨🇺🇸🇮🇷 BREAKING

The Trump administration and Iran are reportedly close to a deal to end the war

The only thing standing b…

[Mario Nawfal @MarioNawfal]

🇲🇾The MH370 video compared to the recent Department of War UFO files drop.

The perspectives look weirdly similar… both allegedly over the South China Sea.

That rabbit hole never ends.